STOCK TITAN

Fortress Biotech to Present at ROTH MKM 2023 Healthcare Opportunities Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
conferences
Rhea-AI Summary
Fortress Biotech to present corporate overview at ROTH MKM 2023 Healthcare Opportunities Conference
Positive
  • None.
Negative
  • None.

MIAMI, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will present a corporate overview at the ROTH MKM 2023 Healthcare Opportunities Conference in New York City on Thursday, October 12, 2023, at 11:00 a.m. ET.

About Fortress Biotech
Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates. The company has eight marketed prescription pharmaceutical products and over 25 programs in development at Fortress, at its majority-owned and majority-controlled partners and subsidiaries and at partners and subsidiaries it founded and in which it holds significant minority ownership positions. Such product candidates span six large-market areas, including oncology, rare diseases and gene therapy, which allow it to create value for shareholders. Fortress advances its diversified pipeline through a streamlined operating structure that fosters efficient drug development. The Fortress model is focused on leveraging its significant biopharmaceutical industry expertise and network to further expand the company’s portfolio of product opportunities. Fortress has established partnerships with some of the world’s leading academic research institutions and biopharmaceutical companies to maximize each opportunity to its full potential, including AstraZeneca, City of Hope, Fred Hutchinson Cancer Center, St. Jude Children’s Research Hospital, Nationwide Children’s Hospital and Sentynl. For more information, visit www.fortressbiotech.com.

Company Contact:
Jaclyn Jaffe
Fortress Biotech, Inc.
(781) 652-4500
ir@fortressbiotech.com

Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
tplohoros@6degreespr.com


FAQ

When will Fortress Biotech present at the ROTH MKM 2023 Healthcare Opportunities Conference?

Fortress Biotech will present on Thursday, October 12, 2023, at 11:00 a.m. ET.

Who will be presenting for Fortress Biotech?

Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will be presenting.

What is Fortress Biotech's focus?

Fortress Biotech is focused on acquiring, developing, and commercializing or monetizing therapeutic products and candidates.

Fortress Biotech, Inc.

NASDAQ:FBIO

FBIO Rankings

FBIO Latest News

FBIO Stock Data

43.62M
21.76M
21.21%
15.78%
9.51%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BAY HARBOR ISLANDS